go back

Lisocabtagene Maraleucel (Breyanzi) CAR-T Therapy

Arizona rates for HCPCS Q2054

Lisocabtagene maraleucel, up to 110 million autologous anti-CD19 CAR-positive viable T cells, including leukapheresis and dose preparation procedures, per therapeutic dose

Rates data updated July 2026.

Facilitymedian $616,595 · 10th–90th $3$1,148,1540%20%10th90th$616,595Professionalmedian $562,341 · 10th–90th $562,341$676,0830%50%90th$562,341$0.5$10.0$200.0$5.0K$100.0K$2.0M

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$812,830.52
Median
$977,237.22
Typical High
$1,202,264.43
Aetna
Setting
Professional
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$676,082.98
BCBS
Setting
Facility
Modifier
Global
Typical Low
$0.87
Median
$3.39
Typical High
$6.61
BCBS
Setting
Professional
Modifier
Global
Typical Low
$0.71
Median
$0.91
Typical High
$1.45
Cigna
Setting
Professional
Modifier
Global
Typical Low
$537,031.80
Median
$588,843.66
Typical High
$1,047,128.55
Medica
Setting
Facility
Modifier
Global
Typical Low
$489,778.82
Median
$616,595.00
Typical High
$954,992.59
Medica
Setting
Professional
Modifier
Global
Typical Low
$977,237.22
Median
$977,237.22
Typical High
$977,237.22
United
Setting
Facility
Modifier
Global
Typical Low
$562,341.33
Median
$562,341.33
Typical High
$562,341.33
United
Setting
Professional
Modifier
Global
Typical Low
$346,736.85
Median
$562,341.33
Typical High
$707,945.78